Table 2. (b) Edoxaban.
| CKD | Non-CKD | P value | |
|---|---|---|---|
| N | 107 (40.0) | 160 (60.0) | |
| Age (years) | 80.1±6.9 | 67.6±8.5 | <0.01 |
| Male (%) | 44 | 73 | <0.01 |
| Appropriate dose (%) | 91.5 | 83.8 | 0.25 |
| Body-weight (kg) | 50.1±8.8 | 63.0±10.3 | <0.01 |
| Ccr (ml/min) | 36.9±9.9 | 73.0±16.0 | <0.01 |
| CHADS2 score | 2.39±1.26 | 1.69±1.03 | <0.01 |
| CHA2DS2-VASc score | 4.02±1.60 | 2.69±1.57 | <0.01 |
| HAS-BLED score | 2.15±0.93 | 1.67±0.99 | <0.01 |
| Any cause death (per 100-patient years) | 1.5 | 0.0 | 0.58 |
| Major bleeding (per 100-patient years) | 3.5 | 1.8 | 0.36 |
| Stroke/systemic emboli (per 100-patient years) | 0.0 | 1.8 | 0.51 |